85 related articles for article (PubMed ID: 7440704)
1. Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
Gonzalez-Villapando C; Szabo M; Frohman LA
J Clin Endocrinol Metab; 1980 Dec; 51(6):1417-24. PubMed ID: 7440704
[No Abstract] [Full Text] [Related]
2. Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
Genazzani AR; De Leo V; Murru S; Cocchi D; Camanni F; Müller EE
J Clin Endocrinol Metab; 1982 Feb; 54(2):429-35. PubMed ID: 7054227
[No Abstract] [Full Text] [Related]
3. Agreement of prolactin response to cimetidine and nomifensine in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
Iodice M; Lombardi G; Tommaselli A; Rossi R; Annunziato L; Minozzi M
Neuroendocrinology; 1982 Nov; 35(5):333-5. PubMed ID: 7145025
[No Abstract] [Full Text] [Related]
4. Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.
Barbarino A; De Marinis L; Maira G; Menini E; Anile C
J Clin Endocrinol Metab; 1978 Nov; 47(5):1148-51. PubMed ID: 122421
[TBL] [Abstract][Full Text] [Related]
5. Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors.
Crosignani PG; Ferrari C; Malinverni A; Barbieri C; Mattei AM; Caldara R; Rocchetti M
J Clin Endocrinol Metab; 1980 Nov; 51(5):1068-73. PubMed ID: 7419682
[No Abstract] [Full Text] [Related]
6. Cimetidine and L-dopa in the control of prolactin secretion in man.
Pontiroli AE; Pellicciotta G; Alberetto M; De Pasqua A; Girardi AM; Pozza G
Horm Metab Res; 1979 Mar; 11(3):257-8. PubMed ID: 447211
[No Abstract] [Full Text] [Related]
7. [Role of H2 receptors in controlling prolactin release. Decreased response to cimetidine in patients with prolactin-secreting adenoma and idiopathic hyperprolactinemia].
Bacchi Modena A; Vadora E; Fiaschetti D; Micucci G; Lombardozzi L
Minerva Ginecol; 1984 Jun; 36(6):293-7. PubMed ID: 6540847
[No Abstract] [Full Text] [Related]
8. Cimetidine effects on prolactin release and production.
Barber SG; Hoare AM
Horm Metab Res; 1979 Mar; 11(3):220-1. PubMed ID: 447203
[TBL] [Abstract][Full Text] [Related]
9. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
Fine SA; Frohman LA
J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
[TBL] [Abstract][Full Text] [Related]
10. Functional studies of dopamine control of prolactin secretion in normal women and women with hyperprolactinemic pituitary microadenoma.
Quigley ME; Judd SJ; Gilliland GB; Yen SS
J Clin Endocrinol Metab; 1980 Jun; 50(6):994-8. PubMed ID: 7372794
[No Abstract] [Full Text] [Related]
11. Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.
Molitch ME; Goodman RH; Post KD; Biller BJ; Moses AC; King LW; Feldman ZT; Reichlin S
J Clin Endocrinol Metab; 1982 Dec; 55(6):1118-23. PubMed ID: 7130339
[TBL] [Abstract][Full Text] [Related]
12. Nomifensine: diagnostic test in hyperprolactinemic states.
Müller EE; Genazzani AR; Murru S
J Clin Endocrinol Metab; 1978 Dec; 47(6):1352-7. PubMed ID: 263356
[TBL] [Abstract][Full Text] [Related]
13. [Progress in the hormonal detection of pituitary prolactin adenoma].
De Gennes JL; Turpin G; Heshmati HM; Carayon A
Ann Med Interne (Paris); 1982; 133(1):12-6. PubMed ID: 7065584
[No Abstract] [Full Text] [Related]
14. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
Serri O; Beauregard H; Somma M; Comtois R; Jilwan N; Hardy J
Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
[TBL] [Abstract][Full Text] [Related]
15. Two diagnostic pitfalls mimicking a prolactin-secreting microadenoma.
D'Ercole M; Della Pepa GM; Carrozza C; Bianchi A; Doglietto F
J Clin Endocrinol Metab; 2010 Dec; 95(12):5171. PubMed ID: 21131538
[No Abstract] [Full Text] [Related]
16. Galactorrhea-amenorrhea and hyperprolactinemia associated with pituitary tumors of growth-hormone- and adrenocorticotropic-hormone-secreting cells. A report of two cases.
Haney AF; McCarty KS; Hammond CB
J Reprod Med; 1984 Dec; 29(12):883-7. PubMed ID: 6097688
[TBL] [Abstract][Full Text] [Related]
17. Prolactin response to perphenazine. A sensitive and specific test for pituitary tumor in hyperprolactinemic women.
Mattox JH; Fortunato SJ
J Reprod Med; 1986 Dec; 31(12):1098-101. PubMed ID: 3795197
[TBL] [Abstract][Full Text] [Related]
18. Effect of cimetidine on prolactin-secretion and glucose tolerance in men.
Eversmann T; Landgraf R; Londong W; von Werder K
Horm Metab Res; 1979 Jun; 11(6):412-3. PubMed ID: 468105
[No Abstract] [Full Text] [Related]
19. Cimetidine, an H2-antihistamine, stimulates prolactin secretion in man.
Carlson HE; Ippoliti AF
J Clin Endocrinol Metab; 1977 Aug; 45(2):367-70. PubMed ID: 18488
[TBL] [Abstract][Full Text] [Related]
20. Failure of drugs acting on H2-receptors to modify plasma prolactin levels in pituitary adenomas: evidence for a suprapituitary locus of action.
Scarpignato C; Valenti G; Ceda GP; Bertaccini G
Int Pharmacopsychiatry; 1981; 16(2):79-83. PubMed ID: 7333790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
